The company’s IPO offered 8.8 million shares of common stock at a price of $15 per share to the public.
Piper Jaffray & Co., Barclays Capital and Wells Fargo Securities acted as joint book-running managers for the offering.
K2M is a global medical device company focused on designing, developing and commercializing complex spine technologies, techniques and minimally invasive procedures.
More Articles on Devices:
5 Key Results: LDR’s Mobi-C Artificial Disc Replacement vs. ACDF
FDA Clears AccelSPINE’s Next Generation Minimally Invasive Spine System
Global Medical Device Market to Grow at 6.2% Annually Until 2018
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
